Investors

Stock
Information

MEDINCELL EURONEXT ELIGIBLE PME PEA

Listed on
EURONEXT PARIS / B COMPARTMENT
ISIN code / Ticker
FR0004065605 / MEDCL
Number of shares (February 28, 2023)
25,253,795
Liquidity Provider
KEPLER CHEUVREUX
Analysts
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF
TP ICAP
PORTZAMPARC-BNP PARIBAS GROUP

Download our latest corporate presentation

Share price 02.06.2023 | 17:35 (Paris time)
6.72 €1.66%
Opening6.62 €
Previous closing 6.61 €
Shares traded 34.18 k
Chart by Visualizer

Investors

Events &
Presentations

June 13, 2023

MedinCell Annual results 2022-2023 (Apr. 2022 > Mar. 2023)

September 12, 2023

MedinCell 2023 General Meeting

December 06, 2023

MedinCell Half-Year results (Apr. > Sept. 2023)

PREVIOUS EVENTS

May 02, 2023

Video conference • Approval of UZEDY™

Replay

Transcript

December 06, 2022

Video conference Half Year results

Replay

Transcript Presentation

September 08, 2022

General Meeting (French)

Replay

September 05, 2022

Videoconference • General meeting preparation (French)

Replay

June 14, 2022

Videoconference • Annual results 2021-202

Replay

Transcript Presentation

December 08, 2021

Videoconference • Half Year results

Replay

Transcript Presentation

November 02, 2021

Videoconference • mdc-IRM Phase 3 results

Replay

Transcript

September 01, 2021

Video conference • Portfolio update

Replay

Transcript Presentation

June 16, 2021

Video Conference • Annual results

Replay

Transcript Presentation

December 09, 2020

Video Conference • Half year results

Replay

Transcript

June 04, 2020

Video Conference • Annual results

Replay

Transcript

April 23, 2020

Video Conference • Adapt and overcome to the Covid-19 crisis

Replay

Transcript Presentation

December 03, 2019

Audio conference • Half year results

Replay

Transcript Presentation

June 04, 2019

Audio Conference • Annual results

Replay

Transcript Presentation

December 03, 2018

Audio Conference • Half year results

Replay

Transcript Presentation

Investors

Regulated informations

Investors

General
Meeting

September 2022
September 2021
September 2020
December 2020
September 2019

September 2022

Investors

Contacts

MedinCell

Head of Communication / IR

David Heuzé

david.heuze@medincell.com

+33 (0)6 83 25 21 86

MedinCell

Senior Communications Officer

Nicolas Gourgues

nicolas.gourgues@medincell.com

Investor Relations

NewCap

Louis-Victor Delouvrier & Mathilde Bohin

medincell@newcap.eu

+33 (0)1 44 71 94 94

Media

NewCap

Nicolas Merigeau

medincell@newcap.eu

+33 (0)1 44 71 94 94

Session en français

Rendez-vous le mardi 2 mai à 18h30 pour une vidéoconférence dédiée à l'approbation de UZEDY™

English session

On Tuesday, May 2 at 7.30 pm (CEST) participate in our videoconference dedicated to the approval of UZEDY™

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.